Literature DB >> 24306840

[Incidence rates and risk factors for gastrointestinal perforation in patients with rheumatoid arthritis].

B Walz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24306840     DOI: 10.1007/s00393-013-1277-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  3 in total

1.  Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study.

Authors:  David J Humes; Kate M Fleming; Robin C Spiller; Joe West
Journal:  Gut       Date:  2010-10-12       Impact factor: 23.059

2.  Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions.

Authors:  S Mpofu; C M A Mpofu; D Hutchinson; A E Maier; S R Dodd; R J Moots
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

3.  Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

Authors:  Cem Gabay; Paul Emery; Ronald van Vollenhoven; Ara Dikranian; Rieke Alten; Karel Pavelka; Micki Klearman; David Musselman; Sunil Agarwal; Jennifer Green; Arthur Kavanaugh
Journal:  Lancet       Date:  2013-03-18       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.